AHR Inhibitor I-103

CAS No. 2247951-12-6

AHR Inhibitor I-103( —— )

Catalog No. M37570 CAS No. 2247951-12-6

AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AHR Inhibitor I-103
  • Note
    Research use only, not for human use.
  • Brief Description
    AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.
  • Description
    AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    AhR
  • Recptor
    AhR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2247951-12-6
  • Formula Weight
    372.4
  • Molecular Formula
    C21H17FN6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=CN=CC(=C1)C2=NC3=CC=NN3C(=C2)NCCC4=CNC=5C=CC=CC54
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • YL-109

    YL-109 is a novel anticancer agent which has ability to inhibit breast Y cell growth and invasiveness in vitro and in vivo.

  • StemRegenin 1 (SR1)

    StemRegenin 1 is an aryl hydrocarbon receptor (AhR) inhibitor with IC50 of 127 nM in a cell-free assay.

  • ANI-7

    A potent and selective (up to 263-fold) inhibitor of breast cancer cells with GI50 of 0.5 uM (MCF-7), via activation the aryl hydrocarbon receptor (AhR) pathway.